300871 回盛生物
已收盘 07-08 15:00:00
资讯
新帖
简况
回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%
证券之星 · 07-01
回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%
回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%
证券之星 · 06-29
回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%
回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%
证券之星 · 06-26
回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%
回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%
证券之星 · 06-23
回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%
回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份
智通财经 · 06-08
回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份
回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书
证券之星 · 06-05
回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书
回盛生物：公司取得的米氮平软膏已上市销售
证券之星 · 05-29
回盛生物：公司取得的米氮平软膏已上市销售
回盛生物（300871）披露终止向特定对象发行股票审核决定公告，5月25日股价下跌3.38%
证券之星 · 05-25
回盛生物（300871）披露终止向特定对象发行股票审核决定公告，5月25日股价下跌3.38%
回盛生物不超2.5亿定增到期失效 保荐机构为中信建投
中金财经 · 05-25
回盛生物不超2.5亿定增到期失效 保荐机构为中信建投
回盛生物最新公告：深交所终止对公司向特定对象发行股票审核
证券之星 · 05-22
回盛生物最新公告：深交所终止对公司向特定对象发行股票审核
回盛生物(300871.SZ)发布一季度业绩，归母净利润7767.47万元，增长74.56%
智通财经 · 04-27
回盛生物(300871.SZ)发布一季度业绩，归母净利润7767.47万元，增长74.56%
回盛生物(300871)3月31日股东户数2.3万户，较上期增加15.32%
证券之星 · 04-27
回盛生物(300871)3月31日股东户数2.3万户，较上期增加15.32%
回盛生物涨5.81%，西南证券五日前给出“买入”评级
证券之星 · 04-27
回盛生物涨5.81%，西南证券五日前给出“买入”评级
黄果任国家药监局党组书记；全国四成统筹地区已完成上年度清算
21世纪经济报道 · 04-17
黄果任国家药监局党组书记；全国四成统筹地区已完成上年度清算
回盛生物（300871）披露2025年年度报告，4月16日股价上涨1.6%
证券之星 · 04-16
回盛生物（300871）披露2025年年度报告，4月16日股价上涨1.6%
图解回盛生物年报：第四季度单季净利润同比增长137.25%
证券之星 · 04-16
图解回盛生物年报：第四季度单季净利润同比增长137.25%
回盛生物(300871.SZ)发布2025年度业绩，扭亏为盈至2.53亿元
智通财经 · 04-16
回盛生物(300871.SZ)发布2025年度业绩，扭亏为盈至2.53亿元
回盛生物（300871）披露延长2024年度向特定对象发行A股股票决议有效期公告，4月3日股价下跌5.66%
证券之星 · 04-03
回盛生物（300871）披露延长2024年度向特定对象发行A股股票决议有效期公告，4月3日股价下跌5.66%
回盛生物（300871）披露为全资孙公司提供1000万元担保公告，3月27日股价上涨3.25%
证券之星 · 03-27
回盛生物（300871）披露为全资孙公司提供1000万元担保公告，3月27日股价上涨3.25%
回盛生物（300871）披露2026年员工持股计划非交易过户完成公告，3月20日股价下跌3.3%
证券之星 · 03-20
回盛生物（300871）披露2026年员工持股计划非交易过户完成公告，3月20日股价下跌3.3%
加载更多
公司概况
公司名称：
武汉回盛生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2020-08-24
主营业务：
武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是经济动物用重点产品、宠物用重点产品。公司是农业产业化国家重点龙头企业和全国农业农村信息化示范基地。截至2025年12月31日，公司已取得兽药批准文号317个。
发行价格：
33.61
{"stockData":{"symbol":"300871","market":"SZ","secType":"STK","nameCN":"回盛生物","latestPrice":23.03,"timestamp":1783494216000,"preClose":23.62,"halted":0,"volume":7129762,"delay":0,"changeRate":-0.025,"floatShares":202000000,"shares":202000000,"eps":1.4191,"marketStatus":"已收盘","change":-0.59,"latestTime":"07-08 15:00:00","open":23.55,"high":23.88,"low":22.7,"amount":165000000,"amplitude":0.05,"askPrice":23.03,"askSize":25,"bidPrice":22.98,"bidSize":20,"shortable":0,"etf":0,"ttmEps":1.4191,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783560600000},"marketStatusCode":5,"adr":0,"adjPreClose":23.62,"symbolType":"stock","openAndCloseTimeList":[[1783474200000,1783481400000],[1783486800000,1783494000000]],"highLimit":25.98,"lowLimit":21.26,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":201784357,"isCdr":false,"pbRate":2.11,"roa":"--","peRate":16.228596,"roe":"3.51%","epsLYR":1.3349,"committee":-0.33913,"marketValue":4647000000,"turnoverRate":0.0353,"status":1,"floatMarketCap":4647000000},"requestUrl":"/m/hq/s/300871","defaultTab":"news","newsList":[{"id":"2648511907","title":"回盛生物（300871）披露控股股东股权结构变动暨完成工商变更登记的提示性公告，7月1日股价上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511907","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648511907?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:52","pubTimestamp":1782899526,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，回盛生物报收于23.17元，较前一交易日上涨5.03%，最新总市值为46.75亿元。近日，回盛生物发布《关于控股股东股权结构变动暨完成工商变更登记的提示性公告》。本次转让系控股股东内部股权结构调整，不涉及上市公司层面股份变动。转让后，武汉统盛持有回盛生物82,800,000股，持股比例仍为41.03%，公司控股股东仍为武汉统盛，实际控制人仍为张卫元、余姣娥。相关工商变更登记已完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647370252","title":"回盛生物（300871）披露为子公司提供担保的进展公告，6月29日股价上涨4.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647370252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647370252?lang=zh_cn&edition=full","pubTime":"2026-06-29 22:26","pubTimestamp":1782743183,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，回盛生物报收于23.09元，较前一交易日上涨4.06%，最新总市值为46.59亿元。该股当日开盘21.95元，最高23.35元，最低21.48元，成交额达2.2亿元，换手率为4.82%。本次担保在公司已审批的担保额度范围内，无需再次履行审议程序。截至2026年3月31日，其资产总额为167,759.40万元，净资产为119,676.55万元。本次担保后，公司实际担保余额为17,979.25万元，占2025年经审计净资产的8.27%，均为合并报表范围内担保，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900041290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365944","title":"回盛生物（300871）披露调整回购股份价格上限公告，6月26日股价下跌4.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646365944?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:38","pubTimestamp":1782484702,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，回盛生物报收于22.19元，较前一交易日下跌4.64%，最新总市值为44.78亿元。该股当日开盘22.98元，最高23.07元，最低21.99元，成交额达1.63亿元，换手率为3.62%。近日，武汉回盛生物科技股份有限公司发布《关于调整回购股份价格上限的公告》。根据相关规定，自2026年7月6日起，回购股份价格上限由不超过37.20元/股调整为不超过37.00元/股。本次调整系因权益分派除权除息所致，其他回购事项无变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645887592","title":"回盛生物（300871）披露为子公司提供担保的进展公告，6月23日股价上涨1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645887592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645887592?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:53","pubTimestamp":1782208386,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，回盛生物报收于23.04元，较前一交易日上涨1.23%，最新总市值为46.49亿元。该股当日开盘22.6元，最高23.66元，最低22.51元，成交额达1.72亿元，换手率为3.66%。本次担保在公司已审批的担保额度范围内，无需提交董事会或股东会审议。截至目前，公司实际提供担保总余额为15,979.25万元，占2025年经审计净资产的7.35%，均为合并报表范围内担保，无逾期担保。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300031225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100523","title":"回盛生物(300871.SZ)拟3000万元至6000万元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100523","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100523?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:04","pubTimestamp":1780909442,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 回盛生物(300871.SZ)发布公告，公司拟使用自有资金以集中竞价交易方式回购本公司部分社会公众股，回购股份的资金总额不低于人民币3000万元(含)，不超过人民币6000万元(含)，回购价格不超过人民币37.20元/股(含)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451408.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641111539","title":"回盛生物最新公告：子公司获“格拉匹仑片”新兽药注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2641111539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641111539?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:42","pubTimestamp":1780652526,"startTime":"0","endTime":"0","summary":"回盛生物(300871.SZ)公告称，公司子公司湖北回盛生物科技有限公司与其他单位联合申报的“格拉匹仑片”获农业农村部批准为新兽药，并核发《新兽药注册证书》。该药为国产首款新靶点宠物专用解热镇痛药，用于控制犬骨关节炎的疼痛和炎症，安全性更高，适合长期使用。产品待取得兽药产品批准文号后上市，短期内不会对业绩产生重要影响。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500030813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639610857","title":"回盛生物：公司取得的米氮平软膏已上市销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2639610857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639610857?lang=zh_cn&edition=full","pubTime":"2026-05-29 08:54","pubTimestamp":1780016052,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物(300871)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司研发的，猫传染性腹膜炎、犬骨关节炎领域新药和米氮平软膏等5款宠物新药，预计什么时候或已经上市销售了吗？回盛生物回复：尊敬的投资者，您好！公司取得的米氮平软膏已上市销售。宠物医疗是公司战略业务之一。公司拥有独立、专业化的宠物药品研发团队，宠物产品覆盖抗感染、抗寄生虫、抗真菌、镇静止痛、皮肤病和耳药等宠物疾病。公司正加快宠物药品板块布局，利用自身在研发创新方面的优势，丰富产品矩阵，打造新的业务增长极。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900008562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638531401","title":"回盛生物（300871）披露终止向特定对象发行股票审核决定公告，5月25日股价下跌3.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638531401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638531401?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:42","pubTimestamp":1779702141,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，回盛生物报收于22.0元，较前一交易日下跌3.38%，最新总市值为44.39亿元。公司近日披露《关于收到深圳证券交易所终止对公司申请向特定对象发行股票审核决定的公告》。公告显示，武汉回盛生物科技股份有限公司于2026年4月17日召开的2026年第二次临时股东会未审议通过延长2024年度向特定对象发行A股股票决议有效期及相关授权事项，导致该发行方案到期自动失效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500025166.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638538575","title":"回盛生物不超2.5亿定增到期失效 保荐机构为中信建投","url":"https://stock-news.laohu8.com/highlight/detail?id=2638538575","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638538575?lang=zh_cn&edition=full","pubTime":"2026-05-25 14:54","pubTimestamp":1779692047,"startTime":"0","endTime":"0","summary":"中国经济网北京5月25日讯 回盛生物 22日发布关于收到深圳证券交易所终止对公司申请向特定对象发行股票审核决定的公告。 深圳证券交易所网站显示，回盛生物保荐机构为中信建投证券股份有限公司，保荐代表人为陈子晗、张兴华。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260525/32251394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300871","601066","BK0239","BK0276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637390529","title":"回盛生物最新公告：深交所终止对公司向特定对象发行股票审核","url":"https://stock-news.laohu8.com/highlight/detail?id=2637390529","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637390529?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:27","pubTimestamp":1779442060,"startTime":"0","endTime":"0","summary":"回盛生物(300871.SZ)公告称，公司收到深圳证券交易所出具的《关于终止对武汉回盛生物科技股份有限公司申请向特定对象发行股票审核的决定》。因公司2024年度向特定对象发行股票方案已到期自动失效，深交所决定终止对公司申请向特定对象发行股票的审核。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200032227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630673023","title":"回盛生物(300871.SZ)发布一季度业绩，归母净利润7767.47万元，增长74.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630673023","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630673023?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:18","pubTimestamp":1777285112,"startTime":"0","endTime":"0","summary":"智通财经APP讯，回盛生物(300871.SZ)发布2026年第一季度报告，该公司营业收入为4.58亿元，同比增长14.82%。归属于上市公司股东的净利润为7767.47万元，同比增长74.56%。归属于上市公司股东的扣除非经常性损益的净利润为7869.4万元，同比增长130.84%。基本每股收益为0.3839元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630361084","title":"回盛生物(300871)3月31日股东户数2.3万户，较上期增加15.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630361084","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630361084?lang=zh_cn&edition=full","pubTime":"2026-04-27 17:32","pubTimestamp":1777282339,"startTime":"0","endTime":"0","summary":"证券之星消息，近日回盛生物披露，截至2026年3月31日公司股东户数为2.3万户，较12月31日增加3054.0户，增幅为15.32%。在动物保健行业个股中，回盛生物股东户数高于行业平均水平，截至3月31日，动物保健行业平均股东户数为2.26万户。根据统计，回盛生物2025年12月31日至2026年3月31日，主力资金净流出2.44亿元，游资资金净流出1.47亿元，散户资金净流入3.92亿元。期间龙虎榜该股共上榜1次，机构专用席位上榜1次。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700032149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630661653","title":"回盛生物涨5.81%，西南证券五日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630661653","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630661653?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:37","pubTimestamp":1777279055,"startTime":"0","endTime":"0","summary":"今日回盛生物涨5.81%，收盘报28.25元。2026年4月22日，西南证券研究员徐卿,赵磐发布了对回盛生物的研报《2025年年报点评：业绩创新高，原料药与新兴业务驱动高成长》，该研报对回盛生物给出“买入”评级。研报中预计2026-2028年EPS分别为1.65元、1.97元、2.47元，对应动态PE分别为17/14/11倍，维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为23.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700029575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","600369"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628228518","title":"黄果任国家药监局党组书记；全国四成统筹地区已完成上年度清算","url":"https://stock-news.laohu8.com/highlight/detail?id=2628228518","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628228518?lang=zh_cn&edition=full","pubTime":"2026-04-17 08:10","pubTimestamp":1776384629,"startTime":"0","endTime":"0","summary":"政策动向全国四成统筹地区已提速完成上年度清算4月16日，国家医保局发布消息，截至2026年3月31日，全国30个省份（含新疆生产建设兵团）共154个统筹地区完成上年度清算，覆盖率达全国统筹区总数的39%，超额完成试点任务。其中，吉林白山、浙江宁波等43个非试点地区主动对标试点标准同步完成清算任务。山东、宁夏、北京、河北、海南、天津、河南等7个省（区、市）完成全省（区、市）清算。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604173708185460.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604173708185460.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2168564065.EUR","LU2896262040.SGD","LU2462157665.USD","LU2417539215.USD","LU1917777945.USD","LU2491049909.HKD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU2168564222.USD","LU1223082196.USD","LU0114720955.EUR","LU2471134879.HKD","LU2237438978.USD","LU0234572021.USD","LU1366192091.USD","BK4533","IE00B4JS1V06.HKD","LU0158827948.USD","LU0882574055.USD","IE00BJJMRX11.SGD","IE00B775H168.HKD","BK0239","SGXZ99366536.SGD","LU0786609619.USD","LU1804176565.USD","LU1868837300.USD","GB00BDT5M118.USD","IE00BN29S564.USD","IE00B7KXQ091.USD","LU0432979614.USD","LU2089283258.USD","LU0787776722.HKD","LU1868836591.USD","LU2089984988.USD","LU2750360641.GBP","LU0097036916.USD","LU2237443382.USD","LU2168564495.EUR","LU2111349929.HKD","BK4017","IE00B2B36J28.USD","IE00BK4W5M84.HKD","LU0683600562.USD","IE00BJLML261.HKD","LU2552382058.USD","LU1814569148.SGD","SG9999001176.SGD","SG9999013999.USD","LU1868836757.USD","LU1069344957.HKD","SG9999014880.SGD","LU0456855351.SGD","LU0225283273.USD","LU0640476718.USD","LU2168563687.JPY","LU0203201768.USD","SGXZ51526630.SGD","LU2271345857.HKD","LU0198837287.USD","LLII","LU1983299246.USD","LU2471134796.USD","LU1280957306.USD","LU2746668974.SGD","LU0820561818.USD","LU1291159041.SGD","ELIS","LU1988902786.USD","LU2108987350.USD","LU0109391861.USD","SG9999018857.SGD","LU2357305700.SGD","LU2461242641.AUD","IE00BFTCPJ56.SGD","BK4588","IE0001KFT4U8.USD","LU2756315664.SGD","BK4599","SG9999014898.SGD","LU0353189680.USD","LU0354030511.USD","LU0289739699.SGD","LU2213496289.HKD","LU0471298694.HKD","LU0256863811.USD","SG9999015952.SGD","LU0096364046.USD","IE0004445239.USD","LU2456880835.USD","LU2106854487.HKD","SG9999015945.SGD","BK4516","LU2236285917.USD","LU2552382215.SGD","BK4007","LU2361044865.SGD","LU1720051108.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","IE00BKPKM429.USD","LU2746668461.USD","IE00BKDWB100.SGD","SG9999014914.USD","LU0106261372.USD","LU1551013425.SGD","LU0689472784.USD","LU2265009873.SGD","LU2324357040.USD","LU2089284900.SGD","LU0109394709.USD","IE00BJJMRY28.SGD","LU0820561909.HKD","LU0672654240.SGD","LU1868837136.USD","LU2023250330.USD","LU1323610961.USD","LU2602419157.SGD","300871","000919","LU0079474960.USD","LU0820562030.AUD","SG9999014906.USD","LU1093756168.USD","LU2211815571.USD","LU0238689110.USD","LU1974910355.USD","LU2063271972.USD","LU0889565916.HKD","688271","LU0316494557.USD","BK0096","LLYZ","LU0823434740.USD","LU1868836914.USD","LU2237443465.HKD","SG9999001176.USD","LU1127390331.HKD","LU0354030438.USD","LU0158827781.USD","LU1223083913.SGD","BK4534","LU1989771016.USD","SGXZ57979304.SGD","IE0002141913.USD","LU2750360997.AUD","LU0823416689.USD","LU1551013342.USD","LU0256863902.USD","LU1548497426.USD","LU2264538146.SGD","BK4581","LU2361045086.USD","LU0882574139.USD","LU0323591593.USD","BK4082","LU0943347566.SGD","LU2237443978.SGD","LU2468319806.SGD","LLYX","IE00BK4W5L77.USD","BK0028","LU0061475181.USD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU1223082519.USD","LU1623119135.USD","LU0058720904.USD","LU0094547139.USD","LU0133085943.USD","LU1035775433.USD","BK4168","LU0122379950.USD","LU0203202063.USD","SG9999018865.SGD","LU2756315318.SGD","LU0964807845.USD","LU0471298777.SGD","LU1057294990.SGD","LLY","LU2023250504.SGD","LU2087625088.SGD","IE00B1BXHZ80.USD","LU0266013472.USD","LU1629891620.HKD","LU2471134523.USD","LU2361044949.HKD","LU2471134952.CNY","LU2028103732.USD","LU0210536198.USD","LU1145028129.USD","IE0004445015.USD","LU2552382132.HKD","LU2237443895.HKD","IE00BWXC8680.SGD","LU0823434583.USD","LU1267930730.SGD","SG9999015978.USD","BK4585","LU1064131342.USD","IE00B1XK9C88.USD","LU0385154629.USD","LU1093756325.SGD","LU0320765992.SGD","LU2237443622.USD","LU0417517546.SGD","LU1720051017.SGD","PYNKF","LU2237443549.SGD","ELIL","SGXZ31699556.SGD","IE00BFSS7M15.SGD","SG9999017495.SGD","LU1712237335.SGD","LU0006306889.USD","LU0466842654.USD","IE0009355771.USD","LU0353189763.USD","LU1023059063.AUD","LU1232071149.USD","LU2112291526.USD","LU2168564149.EUR","LU2491050154.USD","SG9999015986.USD","LU0708995401.HKD","LU0320765059.SGD","SGXZ81514606.USD","LU2491050071.SGD","LU2360106947.USD","LU2023251221.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627219955","title":"回盛生物（300871）披露2025年年度报告，4月16日股价上涨1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627219955","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627219955?lang=zh_cn&edition=full","pubTime":"2026-04-16 22:04","pubTimestamp":1776348261,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘，回盛生物报收于27.9元，较前一交易日上涨1.6%，最新总市值为56.3亿元。该股当日开盘27.25元，最高28.27元，最低27.01元，成交额达5.71亿元，换手率为10.19%。近日，回盛生物披露《2025年年度报告》。报告显示，公司实现营业收入1,681,248,059.49元，同比增长40.07%；归属于上市公司股东的净利润为253,155,975.55元，同比扭亏为盈，增幅达1,356.01%；扣除非经常性损益后的净利润为230,559,616.54元，同比增长1,519.83%。经营活动产生的现金流量净额为238,448,397.00元，同比增长447.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600043003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627929302","title":"图解回盛生物年报：第四季度单季净利润同比增长137.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627929302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627929302?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:07","pubTimestamp":1776330447,"startTime":"0","endTime":"0","summary":"证券之星消息，回盛生物2025年年报显示，当年度公司主营收入16.81亿元，同比上升40.07%；归母净利润2.53亿元，同比上升1356.01%；扣非净利润2.31亿元，同比上升1519.83%；其中2025年第四季度，公司单季度主营收入4.22亿元，同比上升3.42%；单季度归母净利润6524.97万元，同比上升137.25%；单季度扣非净利润6471.26万元，同比上升300.48%；负债率27.33%，投资收益888.61万元，财务费用1291.71万元，毛利率30.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600030194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627260930","title":"回盛生物(300871.SZ)发布2025年度业绩，扭亏为盈至2.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2627260930","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627260930?lang=zh_cn&edition=full","pubTime":"2026-04-16 16:01","pubTimestamp":1776326503,"startTime":"0","endTime":"0","summary":"智通财经APP讯，回盛生物(300871.SZ)发布2025年年度报告，该公司营业收入为16.81亿元，同比增长40.07%。归属于上市公司股东的净利润为2.53亿元。归属于上市公司股东的扣除非经常性损益的净利润为2.31亿元。基本每股收益为1.3349元。此外，拟向全体股东每10股派发现金红利2.00元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429333.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624651410","title":"回盛生物（300871）披露延长2024年度向特定对象发行A股股票决议有效期公告，4月3日股价下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624651410","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624651410?lang=zh_cn&edition=full","pubTime":"2026-04-03 18:21","pubTimestamp":1775211675,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，回盛生物报收于24.98元，较前一交易日下跌5.66%，最新总市值为50.41亿元。公司于近日披露《关于延长公司2024年度向特定对象发行A股股票股东会决议有效期及相关授权有效期的公告》。原有效期至2026年4月18日，现拟延长12个月至2027年4月17日。本次延长事项尚需提交公司2026年第二次临时股东大会审议，关联股东需回避表决。除有效期延长外，本次发行方案其他内容保持不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300035595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159982","BK0239","300871","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622820014","title":"回盛生物（300871）披露为全资孙公司提供1000万元担保公告，3月27日股价上涨3.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622820014","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622820014?lang=zh_cn&edition=full","pubTime":"2026-03-27 22:21","pubTimestamp":1774621281,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，回盛生物报收于23.83元，较前一交易日上涨3.25%，最新总市值为48.22亿元。本次担保金额在公司已审批的50,000万元担保额度范围内，无需另行提交董事会或股东会审议。截至2025年9月30日，其资产总额为8,322.08万元，净资产4,737.27万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700049928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300871","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620323732","title":"回盛生物（300871）披露2026年员工持股计划非交易过户完成公告，3月20日股价下跌3.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620323732","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620323732?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:19","pubTimestamp":1774016360,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，回盛生物报收于24.05元，较前一交易日下跌3.3%，最新总市值为48.66亿元。该股当日开盘24.89元，最高25.17元，最低24.02元，成交额达1.82亿元，换手率为3.69%。公告显示，武汉回盛生物科技股份有限公司已完成2026年员工持股计划非交易过户。本次员工持股计划股票来源为公司回购专用账户中的A股普通股，共205,400股，占公司总股本的0.10%，过户价格为15.00元/股。公司已开立员工持股计划专用证券账户，相关股份已过户并取得证券过户登记确认书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300871"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783549981459,"stockEarnings":[{"period":"1week","weight":0.0022},{"period":"1month","weight":0.1052},{"period":"3month","weight":-0.0655},{"period":"6month","weight":0.0261},{"period":"1year","weight":0.1057},{"period":"ytd","weight":0.1202}],"compareEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.0029},{"period":"3month","weight":0.0012},{"period":"6month","weight":-0.0363},{"period":"1year","weight":0.1354},{"period":"ytd","weight":0.0005}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"武汉回盛生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"22983人(较上一季度增加15.32%)","perCapita":"8779股","listingDate":"2020-08-24","address":"湖北省武汉市东西湖区新沟街道办事处油纱路52号","registeredCapital":"20178万元","survey":" 武汉回盛生物科技股份有限公司的主营业务是兽用药品(包括化药制剂、原料药、中药制剂)、饲料及添加剂的研发、生产和销售。公司的主要产品是经济动物用重点产品、宠物用重点产品。公司是农业产业化国家重点龙头企业和全国农业农村信息化示范基地。截至2025年12月31日，公司已取得兽药批准文号317个。","listedPrice":33.61},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"回盛生物,300871,回盛生物股票,回盛生物股票老虎,回盛生物股票老虎国际,回盛生物行情,回盛生物股票行情,回盛生物股价,回盛生物股市,回盛生物股票价格,回盛生物股票交易,回盛生物股票购买,回盛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"回盛生物(300871)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供回盛生物(300871)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}